Healthtech Startups
16,401 companies tagged Healthtech, with their investors and founders.
Nabla provides an AI assistant for clinical documentation and workflows, used by healthcare organizations and clinicians. It is deployed across more than 150 health organizations.
4 investors
Nectar Allergy & Asthma is an allergy care platform offering testing, diagnosis, and treatment for food and environmental allergies, asthma, and eczema, including at-home testing kits and custom sublingual immunotherapy drops. It serves patients through in-person clinics in New York City and an online platform for at-home care across most U.S. states.
4 investors
Nelly develops digital solutions to reduce administrative burden for healthcare professionals and improve patient experience. The company digitizes manual healthcare processes to streamline documentation and increase efficiency in the healthcare system.
4 investors
Nema Health provides trauma-focused mental health treatment for patients with PTSD and C-PTSD, using Cognitive Processing Therapy (CPT) delivered by licensed therapists. The company serves patients seeking evidence-based trauma care with virtual access and insurance coordination.
4 investors
Neopenda develops health-technology devices for neonatal care in emerging markets, specifically serving healthcare facilities in underserved populations. The company, structured as a public benefit corporation, focuses on innovative products to improve health outcomes in resource-limited settings.
4 investors
Nervonik develops peripheral nerve stimulation (PNS) systems designed for high-motion, dynamic activity, using a patented technology that adds biosensing and objective feedback to neuromodulation. The systems focus on connectivity, wearability, lead stability, and durability for medical device applications.
4 investors
NeuraLight develops AI-powered digital biomarkers for neurological diseases including Alzheimer's, Parkinson's, and multiple sclerosis. The company uses signal processing and computer vision to enable clinical assessment and disease monitoring for healthcare providers and medical institutions.
4 investors
NeuroBionics develops soft, flexible neural interface technologies for neuromodulation applications. The company translates bioelectronic devices from preclinical research toward first-in-human studies and commercialization.
4 investors
Neurofenix is a tech-enabled virtual care provider that delivers neurorehabilitation therapy to neurological patients at home, including an upper-limb program for stroke survivors. It combines dedicated therapists, gamified therapeutic activities, remote tracking devices, and a monitoring platform (NeuroPlatform) that integrates with existing healthcare systems.
4 investors
Neurona is a clinical-stage biotherapeutics company developing allogeneic, off-the-shelf regenerative neural cell therapies that integrate into neural circuits to treat chronic neurological disorders. Its pipeline includes neuronal, glial, and gene-edited cell therapy candidates led by NRTX-1001, an inhibitory neuron therapy for epilepsy.</parameter> <parameter name="founders">[]
4 investors
NeuroNav provides person-centered planning and independent facilitation services to help individuals with developmental disabilities navigate and utilize self-determination services in California's regional centers. The company uses research-backed approaches to match clients with appropriate support options and services tailored to their life goals.
4 investors
NewAmsterdam Pharma develops innovative therapies for cardiovascular disease and lipid-related conditions. The company aims to provide lipid-lowering treatments that help patients with cardiovascular risk manage their health.
4 investors
Nicolette develops technology to improve interactions between patients and healthcare providers, with a focus on better outcomes, patient experience, care team experience, and cost reduction in healthcare delivery.
4 investors
Nicoya provides digital biosensing instruments for biophysical characterization, enabling scientists to study molecular behavior and protein interactions in drug discovery and structural analysis. The company serves research institutions and biotech discovery teams with label-free binding kinetics, thermal shift screening, and hydrogen-deuterium exchange technologies.
4 investors
Nimble provides digital workflow and patient engagement software for independent and regional pharmacies, helping them manage prescription fulfillment, mobile checkout, and patient communications. The platform improves medication adherence and enables life sciences companies to access commercial intelligence on therapy adoption.
4 investors
Nodal operates a platform connecting surrogates (gestational carriers) and intended parents, with tools and education to support both parties through the surrogacy process. It combines technology with a team of clinicians, nurses, and former surrogates to make surrogacy more accessible and transparent.
4 investors
Noema Pharma develops a late-stage portfolio of oral small molecule therapeutics for people with neurological and related disorders, targeting both orphan and larger indications with significant unmet medical needs. The company works with patients, caregivers, and healthcare professionals throughout discovery and clinical development.
4 investors
Noetik builds AI models to identify cancer patients most likely to respond to treatments and to discover new oncology drug targets. The platform aims to improve clinical trial patient selection and expand the set of viable cancer targets in drug development.
4 investors
Nourish provides personalized medical nutrition therapy and patient education focused on long-term behavior change. The company delivers evidence-based nutritional care recommendations and coordinates with patients' healthcare teams to improve health outcomes.
4 investors
NourishedRx operates a data-driven "Food is Health" platform that pairs clinically guided nutrition plans with support from Registered Dietitians, Health Coaches, and Wellness Associates to address chronic conditions, maternal health, surgical recovery, and nutrition insecurity. It serves health plans, providers, government agencies, and food suppliers seeking to deliver nutrition-first interventions that improve health outcomes and reduce medical spend.
4 investors
NRG Therapeutics is a biotech company developing small-molecule drugs targeting the mitochondrial permeability transition pore (mPTP) for neurodegenerative diseases such as ALS and Parkinson's. Its team combines pharma and biotech drug discovery expertise across neurology and neuroscience.
4 investors
Nuance creates software products, including healthcare solutions for clinical documentation, speech recognition, and virtual assistants. The company is committed to accessibility for users with disabilities.
4 investors
Numerion combines drug discovery expertise with machine learning and computational chemistry. The company applies AI to drug development.
4 investors
NΕ«mi uses cell culture technology to produce a new form of nutrition, aiming to replicate the benefits of breast milk as an alternative for parents and infants, with potential applications across other age groups. It operates in the food and biotech space focused on human nutrition and health.
4 investors